Robert Dubiel

3.2k citations
23 papers · 1.6k · 1 hit paper · h-index 12

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Blood Pressure and Hypertension Studies
    • Cardiac Arrhythmias and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases

Papers in

Robert Dubiel

21 papers receiving 1.5k citations

Robert Dubiel's Hit Papers

Idarucizumab for Dabigatran Reversal 2015 · 1.0k citations
1.0k0+3+7Years since publication2505007501000

Peers

Robert Dubiel
Comparison fields: 5 of 71
  • Internal Medicine 525
  • Cardiology and Cardiovascular Medicine 1.2k
  • Endocrinology, Diabetes and Metabolism 187
  • Critical Care and Intensive Care Medicine 47
  • Neurology 118
Replace Paul A. Reilly with:
Paul A. Reilly United States
Mark J. Antonino United States
Gianluigi Devoto Italy
M Poggi Italy
Naveen Deenadayalu United States
Niels Gadsbøll Denmark
Steven V. Manoukian United States
Pål Smith Norway
Kirk E. Guyer United States
Mikhail Ruda United States
Robert Dubiel relative to Paul A. Reilly United States Paul A. Reilly's profile →
Citations per field
00.5×1.5×1.9×
Paul A. Reilly · 1×
Citations per year

Countries citing papers authored by Robert Dubiel

Since Specialization
Citations

This map shows the geographic impact of Robert Dubiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dubiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dubiel more than expected).

Fields of papers citing papers by Robert Dubiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Dubiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dubiel. The network helps show where Robert Dubiel may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Dubiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Dubiel Line = papers co-authored together Robert Dubiel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Idarucizumab for Dabigatran Reversal
Hit paper breakdown →
20151041
2 2015114
3 2005100
4
A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
200067
5 200740
6 201035
7 200932
8 200729
9 200824
10 200714
11 201114
12 200913
13 20168
14 20156
15
Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study
20155
16 20155
17 20125
18 20094
19 20103
20
Initial results of the re-verse AD trial: idarucizumab reverses the anticoagulant effects of dabigatran in patients in an emergency setting of major bleeding, urgent surgery, or interventions
20152

About Robert Dubiel

Robert Dubiel is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Nutrition and Dietetics and Internal Medicine, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (16 papers), Hormonal Regulation and Hypertension (8 papers), Atrial Fibrillation Management and Outcomes (7 papers), Sodium Intake and Health (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Acute Myocardial Infarction Research (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Renin-Angiotensin System Studies (2 papers). The work is most often cited by research in Internal Medicine (525 citations), Cardiology and Cardiovascular Medicine (1.2k citations), Endocrinology, Diabetes and Metabolism (187 citations), Critical Care and Intensive Care Medicine (47 citations) and Neurology (118 citations). Robert Dubiel has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Thorsten Steiner, Jeffrey I. Weitz, Menno V. Huisman, Frank W. Sellke, Jerrold H. Levy, CW Kam, John W. Eikelboom, Stephan Glund, Elaine M. Hylek and Joachim Stangier. Their work appears in journals such as American Journal of Cardiovascular Drugs, Journal of Clinical Hypertension, American Journal of Hypertension, Thrombosis and Haemostasis and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact